Cytek Biosciences Inc (CTKB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CTKB | EBS | NMRA | ||
| Company | Cytek Biosciences Inc | Emergent Biosolutions | Neumora Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | ||
| Open | 4.30 | 10.80 | 3.48 | ||
| High | 4.44 | 11.23 | 3.49 | ||
| Low | 4.24 | 10.71 | 3.34 | ||
| Latest | 4.43 | 10.93 | 3.39 | ||
| Change | +0.09 | -0.06 | -0.09 | ||
| % Change | +2.07% | -0.55% | -2.59% | ||
| Volume | 667,900 | 567,500 | 721,500 | ||
| 20-Day Average Volume | 855,745 | 569,185 | 1,690,920 | ||
| Previous Close | 4.34 | 10.99 | 3.48 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 4.68 | 11.27 | 2.56 | ||
| 20-Day Raw Stochastic | 22.92% | 26.17% | 85.06% | ||
| 20-Day Relative Strength | 41.27 | 45.34 | 70.46 | ||
| Weighted Alpha | -3.82 | +18.27 | -7.23 | ||
| Today's Opinion | 8% Sell | 24% Buy | 88% Buy | ||
| Previous Opinion | 8% Buy | 32% Buy | 88% Buy | ||
| Last Month's Opinion | 100% Buy | 56% Buy | 24% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.24% since 02/12/26 | +0.74% since 02/12/26 | +4.31% since 02/12/26 | ||
| Low | 4.10 on 02/17/26 | 10.54 on 02/19/26 | 3.14 on 02/13/26 | ||
| High | 4.44 on 02/20/26 | 11.23 on 02/13/26 | 3.65 on 02/18/26 | ||
| 1-Month | |||||
| %Chg | -16.57% since 01/20/26 | -1.53% since 01/20/26 | +81.28% since 01/20/26 | ||
| Low | 4.09 on 02/12/26 | 10.40 on 02/06/26 | 1.85 on 01/21/26 | ||
| High | 5.70 on 01/22/26 | 12.58 on 01/22/26 | 3.65 on 02/18/26 | ||
| 3-Month | |||||
| %Chg | -14.97% since 11/20/25 | +20.37% since 11/20/25 | +43.64% since 11/20/25 | ||
| Low | 4.09 on 02/12/26 | 9.02 on 11/21/25 | 1.50 on 01/06/26 | ||
| High | 6.04 on 01/12/26 | 14.06 on 01/07/26 | 3.65 on 02/18/26 | ||
| 6-Month | |||||
| %Chg | +10.75% since 08/20/25 | +18.16% since 08/20/25 | +110.56% since 08/20/25 | ||
| Low | 3.28 on 09/25/25 | 7.45 on 09/08/25 | 1.42 on 09/17/25 | ||
| High | 6.18 on 11/17/25 | 14.06 on 01/07/26 | 3.65 on 02/18/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 566,442 | 574,044 | 566,432 | ||
| Shares Outstanding, K | 127,865 | 52,520 | 167,089 | ||
| Annual Sales | 200,450,000 | 1,043,600,000 | 0 | ||
| Annual Net Income | -6,020,000 | -190,600,000 | -243,790,000 | ||
| Last Quarter Sales | 52,290,000 | 231,100,000 | 0 | ||
| Last Quarter Net Income | -5,480,000 | 51,200,000 | -56,760,000 | ||
| 60-Month Beta | 1.30 | 2.35 | 3.20 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.01 on 11/05/25 | 1.06 on 10/29/25 | -0.35 on 11/06/25 | ||
| Latest Earnings Date | 02/26/26 | 02/26/26 | 03/02/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 5.55 | 0.00 | ||